Fauci says coronavirus deaths will keep rising even as new U.S. cases stabilize

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, says the U.S. is "struggling" to get the spread of coronavirus under control.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news

Related Links:

In the thick of the coronavirus pandemic, it might be hard to tell if you've come down with COVID-19, spring allergies or a cold, which all have some similar symptoms.
Source: WebMD Health - Category: Consumer Health News Source Type: news
THURSDAY, June 4, 2020 -- In the thick of the coronavirus pandemic, it might be hard to tell if you've come down with COVID-19, spring allergies or a cold, which all have some similar symptoms. Fever and dry cough are common symptoms of COVID-19,...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
The United States should have 100 million doses of one candidate coronavirus vaccine by the end of the year, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases and a member of the White House Coronavirus Task Force, said Tuesday.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
WEDNESDAY, June 3, 2020 -- According to Anthony Fauci, M.D., director of the U.S. National Institute of Allergy and Infectious Diseases, 100 million doses of a coronavirus vaccine will be available by year's end. " Then, by the beginning of 2021, we...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
The United States should have 100 million doses of one candidate coronavirus vaccine by the end of the year, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases and a member of the White House Coronavirus Task Force, said Tuesday.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
DiscussionWhile awaiting a vaccine, hygiene measures, social distancing and personal protective equipment are the only primary prophylaxis measures against SARS-CoV-2, but they have not been sufficient to protect our healthcare professionals. Some evidence of thein vitro efficacy of hydroxychloroquine against this virus is known, along with some clinical data that would support the study of this drug in the chemoprophylaxis of infection. However, there are still no data from controlled clinical trials in this regard. If our hypothesis is confirmed, hydroxychloroquine can help professionals fight this infection with more gu...
Source: Trials - Category: Research Source Type: clinical trials
(CNN) — A five-day course of the antiviral drug remdesivir sped recovery in moderately ill patients with pneumonia from Covid-19, drugmaker Gilead Sciences announced in a statement Monday. It’s more evidence that the drug can help patients, however outside experts are not calling this a “game changer” quite yet. Coronavirus patients who were hospitalized, but not sick enough to need oxygen from a ventilator, were more likely to recover after a five-day course of remdesivir than those given the current standard of care alone, Gilead said. The results from the Phase III clinical trial on the drug have...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health CNN Coronavirus remdesivir Source Type: news
CORONAVIRUS symptoms have been shown to manifest themselves in a number of ways, from a persistent cough to aches and pains and diarrhoea. With hay fever season also in full swing, are itchy eyes a sign of a pollen allergy or COVID-19? Dr Hilary Jones has issued his advice.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
The coronavirus disease 2019 (COVID-19) continues to spread across the globe. Healthcare providers, including A/I experts caring for patients with asthma, other allergic conditions, and immune deficiencies, are being stretched thin. As misinformation runs rampant, the AAAAI is committed to providing vetted information about the disease, its impact on patients, and its impact on your practices.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Tags: Reader service Source Type: research
BOSTON (CBS) — Dr. Mallika Marshall is answering your coronavirus-related medical questions. If you have a question for Dr. Mallika, email her or message her on Facebook or Twitter. Can we use public restrooms now? – Heather In general, yes. Typically, when you use a public restroom, you get in and out quickly. But there are some steps you can take to minimize your risk. Wear a mask. Don’t crowd around with others waiting to get into the restroom. Avoid touching surfaces as best you can. And wash your hands well when you’re done, using the paper towel to open the door as you...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Covid-19 Boston, MA Health Healthcare Status Healthwatch Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news
More News: Allergy | Allergy & Immunology | Coronavirus | COVID-19 | Health | Infectious Diseases